Star Combo Pharma Limited (ASX:S66)

Star Combo Pharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 8, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	16	15	15	21	34	54
Market Cap Growth	-3.45%	-	-28.77%	-39.31%	-36.64%	-9.80%
Enterprise Value	7	10	10	10	18	56
Last Close Price	0.12	0.11	0.11	0.15	0.25	0.39
PE Ratio	17.30	19.88	-	-	-	-
PS Ratio	0.53	0.57	0.60	0.91	1.27	1.39
PB Ratio	0.46	0.44	0.45	0.59	0.95	1.22
P/TBV Ratio	0.47	0.46	0.46	0.60	1.02	1.54
P/OCF Ratio	3.03	-	7.92	39.07	103.68	-
EV/Sales Ratio	0.23	0.38	0.42	0.45	0.65	1.44
EV/EBITDA Ratio	3.31	5.76	6.40	28.43	-	-
EV/EBIT Ratio	7.87	10.80	9.28	-	-	-
Debt / Equity Ratio	0.12	0.12	0.13	0.12	0.09	0.13
Debt / EBITDA Ratio	1.94	2.03	2.57	6.96	-	-
Debt / FCF Ratio	0.95	-	-	-	-	-
Asset Turnover	0.70	0.61	0.58	0.53	0.55	0.96
Inventory Turnover	5.58	3.85	4.16	3.81	4.76	6.77
Quick Ratio	2.91	2.43	3.13	3.28	5.61	6.37
Current Ratio	3.80	3.77	4.18	4.76	7.45	7.58
Return on Equity (ROE)	2.67%	2.24%	-11.66%	-1.94%	-19.52%	-1.08%
Return on Assets (ROA)	1.26%	1.36%	1.64%	-0.09%	-2.53%	-2.45%
Return on Capital (ROIC)	1.41%	1.54%	1.82%	-0.10%	-2.76%	-2.84%
Return on Capital Employed (ROCE)	2.20%	2.40%	3.00%	-	-	-
Earnings Yield	5.78%	5.03%	-26.94%	-3.34%	-22.91%	-0.64%
FCF Yield	26.69%	-11.83%	-5.71%	-32.41%	-20.15%	-6.89%
Dividend Yield	3.22%	3.44%	-	-	-	-
Buyback Yield / Dilution	-	-	-0.37%	0.15%	-47.45%	-11.29%
Total Shareholder Return	3.22%	3.44%	-0.37%	0.15%	-47.45%	-11.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.